Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial

S-CitAD Research Group

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences